Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 7 Issue 2

"Covid-19 - Post-Covid Syndrome" Pandemic: High Risks for Pregnant Women

Krashenyuk AI*

Academy of Hirudotherapy, St.- Petersburg, Russia

*Corresponding Author: Krashenyuk AI, Academy of Hirudotherapy, St.- Petersburg, Russia.

Received: December 14, 2022; Published: January 13, 2023


The article discusses the mechanism of the disease "Covid-19 - Postcovid Syndrome". The mechanisms of pathogenesis of this disease in pregnant women are affected. The most proven mechanisms of the pathogenesis of the disease and the most correct methods of treatment according to the literature data are investigated. In comparative terms, the advantage of the "System Method of Leeching" in comparison with the proposed methods of treatment is shown. The possibility of monotherapy with medical leeches (hirudotherapy) of this disease and recommendations for pregnant women at risk of the disease are shown.

Keywords: Disease "COVID-19 - Postcovid Syndrome"; Damage to the Nervous System (Central and Peripheral); Endothelial Damage; Microthrombosis; Depression; "System Method of Leeching" (SML); Hirudotherapy; Neurotrophic Effect; Thrombolysis; Immunomodulatory Effect; Detoxification Effect; the Wave Effect; The Effect of Nitric Oxide Production - NO


  1. Krashenyuk AI and Krashenyuk SV. “New understanding of Ancient Technology -Leech therapy. Abstracts for 11th European Congress for Integrative Medicine”. International Journal of Integrative Medical Sciences 43 (2018): 195.
  2. Krashenyuk AI. “The Renaissance of hirudotherapy in Russia: The end of XX and the beginning XXI century”. Journal of Regenerative Medicine 8 (2019): 42.
  3. Krashenyuk AI. “Neurotrophic (Neural Stimulating) and Neuromediator Effects of Hirudo medicinalis. Pathogenetic Mechanism of Treatment of Diseases of the Nervous System of the Human”. Acta Scientific Medical Sciences3 (2020): 01-06.
  4. Krashenyuk AI. “Coronavirus COVID-19 - Theoretical and Practical Substantiations for Reducing Mortality from Complications”. Acta Scientific Medical Sciences6 (2020): 115-123.
  5. Krashenyuk AI. “Aquapathogenesis is the Nature of Human Diseases. Dynamic Hirudotests: New Possibilities of Integral Diagnostics of the State of Human Bodies and his Systems -Study of the Dynamism of the Human Aquasystem”. Acta Scientific Medical Sciences10 (2020): 76-90.
  6. Krashenyuk AI. “Covid-19: Prospects for the Treatment and Rehabilitation of «POST-COVID SYNDROME» by Ayurvedic Method - Hirudotherapy”. Acta Scientific Medical Sciences 5 (2021): 133-144.
  7. Krashenyuk AI. “«Covid-19»: The Importance of the Renaissance of Hirudotherapy to Overcome the Pandemic in Russia and in the World”. Journal of Clinical Case Studies, Reviews and Reports5 (2021): 1-8.
  8. Krashenyuk AI and Burkhonov AB. “Aseptic Necrosis of the Joints, As A Complications of «Post-COVID Syndrome» (Clinical Case)”. Journal of Clinical Case Studies, Reviews and Reports3 (2022): 1-6.
  9. Krashenyuk AI. “Hirudotherapy and Scientific Arguments Substantiation of Pathogenic Treatment «POST - COVID SYNDROME»”. Journal of Integrative Medicine Research and Reports2 (2022): 1-10
  10. Krashenyuk AI. “COVID-19: Is there any legitimate optimism in the treatment of «POST-COVID syndrome» and complication from vaccination? 2nd Edition of International Conference on TRADITIONAL MEDICINE, ETNOMEDICINE AND NATURAL THERAPIES”. Virtual Event 18-19 (2022): 22-23
  11. Krashenyuk AI. “COVID-19 - POST - COVID SYNDROME” Pandemic: Solutions of the Problem are Visible in the Application of Modern Hirudotherapy and Integrative Medicine”. Open Access Journal of Biomedical Science3 (2022): 1907-1909.
  12. Krashenyuk AI. “COVID-19 - POSTCOVID SYNDROME” Pandemic: How to Protect Doctors and Nurses in the “Red Zone” of Hospital?” Journal of Medical and Clinical Nursing4 (2022): 1-9.
  13. Krashenyuk AI. "COVID-19 - POST-COVID SYNDROME" Pandemic: Complex Treatment with Medical Leeches, Including Detoxification. Confirmation of the Validity of The "HOMOTOXICOLOGY" of H. - H. RECKEVEG”. Journal of Clinical Epidemiology and Toxicology4 (2022): 1-7
  14. Krashenyuk AI. "COVID-19 - POST-COVID SYNDROME" Pandemic: The Problem is Solved by Information Medicine - Hirudotherapy”. PriMera Scientific Medicine and Public Health4 (2022), 05-09
  15. Sanaeva MD and Dudareva Yu A. “Disease course, obstetric and perinatal outcomes in pregnant women with COVID-19 (literature review)”. Lechaschi Vrach 5-6.25 (2022): 20-24. DOI: 10.51793/OS.2022.25.6.003
  16. Galang R R., et al. “Severe coronavirus infections in pregnancy: a systematic review”. Obstetrics and Gynecology 2 (2020): 262-272.
  17. Allotey J., et al. “Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis”. BMJ 370 (2020).
  18. Makatsaria AD., et al. “Coronavirus infection (COVID-19) and disseminated intravascular coagulation syndrome”. Gynecology and Reproduction 14.2 (2020): 123-131.
  19. Lecture by Professor P.A. Vorobyov. POSTCOVID SYNDROME.
  20. Mathad J S and Gupta A. “Pulmonary infections in pregnancy”. Seminars in Respiratory and Critical Care Medicine 2 (2017): 174-184.
  21. Perlman S. “Another decade, another coronavirus”. The New England Journal of Medicine8 (2020): 760-762.
  22. Diriba K., et al. “The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis”. European Journal of Medical Research 1 (2020): 39.
  23. Cohen J., et al. “Covid-19 in pregnant women: general data from a French national survey”. European Journal of Obstetrics and Gynecology and Reproductive Biology 1 (2020): 267-268.
  24. Liu D., et al. “Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis”. American Journal of Roentgenology1 (2020): 127-132.
  25. Liu D., et al. “Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis”. American Journal of Roentgenology1 (2020): 127-132.
  26. Gabriel Marín Miguel A., et al. “Maternal, perinatal, and neonatal outcomes with COVID-19: a multicenter study of 242 pregnances and their 248 infant newborns during their first month of life”. The Pediatric Infectious Disease Journal (2020).
  27. Turan O., et al. “Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review”. International Journal of Gynecology and Obstetrics 1 (2020).
  28. Hirshberg A., et al. “Care of critically ill pregnant patients with coronavirus disease 2019: a case series”. American Journal of Gynecology and Obstetrics2 (2020): 286-290.
  29. Knight Dphil M., et al. “Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study”. M.J. 369 (2020): m2107.
  30. San-Juan R., et al. “Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: a single-Centre cohort study from Spain”. Clinical. Medicine 2020; 23 (2020): 100407.
  31. Schwartz DA. “An analysis of 38 pregnant women with «COVID-19», their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes”. Archives of Pathology and Laboratory Medicine 7 (2020): 799-805.
  32. Ellington S., et al. “Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22-June 7, 2020”. Morbidity and Mortality Weekly Report25 (2020): 769-775.
  33. Clerkin K J., et al. “«COVID-19» and cardiovascular disease”. Circulation 20 (2020): 1648-1655.
  34. Thompson J L., et al. “«COVID-19»-related disease severity in pregnancy”. American Journal of Reproductive Immunology (2020).
  35. Juusela A., et al. “Two cases of coronavirus 2019-related cardiomyopathy in pregnancy”. American Journal of Obstetrics and Gynecology MFM2 (2020): 100113.
  36. Hirshberg A., et al. “Care of critically ill pregnant patients with coronavirus disease 2019: a case series”. American Journal of Gynecology and Obstetrics2 (2020): 286-290.
  37. Ellington S., et al. “Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22-June 7, 2020”. Morbidity and Mortality Weekly Report 25 (2020): 769-775.
  38. Kim G U., et al. “Clinical characteristics of asymptomatic and symptomatic patients with mild «COVID-19»”. Clinical Microbiology and Infection7 (2020): 948.e1-948.e3.
  39. WHO Director-General’s opening remarks at the media briefing on COVID-19 (2020).
  40. Perlman S. “Another decade, another coronavirus”. The New England Journal of Medicine8 (2020): 760-762.
  41. Ferrazzi E., et al. “Mode of delivery and clinical findings in COVID19 infected pregnant women in northern Italy”. SSRN Electron Journal (2020).
  42. Flaherman V J., et al. “Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study”. Clinical Infectious Diseases (2020).
  43. Fenizia C., et al. “Analysis of SARS-CoV-2 vertical transmission during pregnancy”. Nature Communication 1 (2020): 5128.
  44. Carosso A., et al. “How to reduce delivery?”. European Journal of Obstetrics and Gynecology and Reproductive Biology 250 (2020): 246249.
  45. Baergen R N., et al. “Placental pathology in Covid-19 positive mothers: preliminary findings”. Pediatric and Developmental Pathology3 (2020): 177-180.
  46. Chen S., et al. “Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases”. Zhonghua bing li xue za zhi = Chinese Journal of Pathology 49 (2020).
  47. Kuhrt K., et al. “Placental abruption in a twin pregnancy at 32 weeks’ gestation complicated by coronavirus disease 2019 without vertical transmission to the babies”. American Journal of Obstetrics and Gynecology 3 (2020): 100135.
  48. Baud D., et al. “Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection”. JAMA 21 (2020): 2198-2200.
  49. What’s new | COVID-19 Treatment Guidelines; (2020).
  50. Chen H., et al. “Clinical characteristics and intrauterine vertical transmission potential of «COVID-19» infection in nine pregnant women: a retrospective review of medical records”. Lancet 10226 (2020): 809-815.
  51. Wei M., et al. “Novel coronavirus infection in hospitalized infants under 1 year of age in China”. JAMA 13 (2020): 1313-1314.
  52. Zhu H., et al. “Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia”. Translational Pediatrics 1 (2020): 51-60.
  53. Zeng L., et al. “Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with «COVID-19» in Wuhan, China”. JAMA Pediatrics7 (2020): 722-725.
  54. Baskova IP and Isakhanyan GS. “Hirudotherapy”. Science and Practice (2004): 507.
  55. Baskova IP. “Scientific foundations of hirudotherapy”. Humoral Link (2015): 189.
  56. Kazennova YuS., et al. “Correction of hemostasiological disorders using hirudopharmacotherapy in pregnant women with fetal development delay”. Collection of materials of the XIII Russian National Congress "Man and Medicine". (2006): 153.
  57. Kazennova YuS., et al. “Conceptual scheme for the treatment of fetal development delay with the use of hirudopharmacotherapy”. Theses of reports of the VII Russian Forum "Mother and Child". (2005): 89-90.
  58. Baskova IP., et al. “Application of the new reagent Cu- Fl for analysis of stimulation of synthesis of NO by the secret of salivary cells of medical leech in the culture of human endothelium (HUVEC) and cardiomycetes of rats”. Biomed Chemistry 58 (2012): 65-76.
  59. Akaike T and Maeda H. “Nitric oxide and virus infection”. Immunology 3 (2000): 300-308.
  60. Ricciardolo FLM. “Multiple roles of nitric oxide in airways”. Thorax 58 (2003): 175-182.
  61. Cao W., et al. “Nitric oxide inhibits the adenovirus proteinase in vitro and viral infectivity in vivo”. FASEB Journal 17 (2003): 2345-2346.
  62. Padalko E., et al. “RNA Peroxynitrite inhibition of coxsackievirus infection by prevention of viral entry”. Proceedings of the National Academy of Sciences of the United States of America 101 (2004): 11731- 11736.
  63. Furchgott RF., et al. “The obligatory role of endothelial cells in relaxation of arterial smooth muscle by acetylcholine”. Nature 288 (1980): 373-376.
  64. Moncada S and EA Higgs. “The discovery of nitric oxide and its role in vascular biology”. British Journal of Pharmacology 147 (2006): 193-201.
  65. Allain A., et al. “Role of nitric oxide in developmental biology in plants, bacteria, and man”. Current Topics in Pharmacology2 (2011): 25-33.
  66. Fang FC. “Antimicrobial reactive oxygen and nitrogen species: concepts and controversies”. Nature Reviews Microbiology 2 (2004): 820-832.
  67. Li H., et al. “Physiological mechanisms regulating the expression of endothelial-type NO synthase”. Nitric Oxide 7 (2002): 132-147.
  68. Lang JD., et al. “Oxidant-Antioxidant Balance in Acute Lung Injury”. Chest 122 (2002): 314-320.
  69. Stamler JS., et al. “Nitrosylation: the prototypic redox-based signaling mechanism”. Cell 106 (2001): 675-683.
  70. Ricciardolo FLM., et al. “Nitric Oxide in Health and Disease of the Respiratory System”. Physiology Review3 (2001): 731-765.
  71. Shi HP., et al. The role of iNOS in wound healing”. Surgery 130 (2001): 225-229.
  72. Wong SH., et al. “Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins”. Proceedings of the National Academy of Sciences of the United States of America51 (2001): 17783-17788.
  73. Lim MN., et al. “Visualization of nitric oxide in living cells by a copper-based fluorescent probe”. Nature Chemical Biology 2 (2006): 375-380.
  74. Pluth MD., et al. “Cell-trappable fluorescent probes for nitric oxide visualization in living cells”. Organic Letter 12 (2010): 2318-2321.
  75. Khardikov AV., et al. “Hirudotherapy in patients with chronical pyelonephritis as method pregravidal course”. The First World Hirudotherapy Congress: scientific conference abstracts. Moscow, September 24-25 (2013): 135-137. Ed.Konstantin Sukhov. Moscow: Norwell Partners Inc., 2013).
  76. Krashenyuk AI andKrashenyuk SV. “Biotherapeutic approaches to reduction of the risk of giving birth to sick children”. Internationaler Medizinischer Kongress. EUROMEDICA. Hannover 31 (2012): 137-138.


Citation: Krashenyuk AI., et al. “"Covid-19 - Post-Covid Syndrome" Pandemic: High Risks for Pregnant Women”.Acta Scientific Medical Sciences 7.2 (2023): 71-82.


Copyright: © 2022 Krashenyuk AI., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US